No. Expected result Indicator Baseline Timing (deadline) Data source Responsible (organization(s), EGs etc) Cross-cutting objectives 1. Sharing and dissemination of relevant actual information between experts, expert groups and partners None 2020 (continuous) EG reports HIV/AIDS&AI EG NDPHS Partner organisations All cross-cutting objectives (see the list above) 2. Cross-sectorial collaboration in the field of HIV & AIs within NDPHS region is promoted None 2020 (continuous) EG reports HIV/AIDS&AI EG NDPHS Partner organisations All cross-cutting objectives 3. Technical support and expertise in developing and in implementing projects and new approaches in partner countries provided as relevant and as requested No and contents of successfully planned, approved and implemented projects, supported by the EG None 2020 Project reports NDPHS reports HIV/AIDS&AI EG NDPHS Selected partner organizations All cross-cutting objectives 3.1. Contribution to prevention: Improved provision and effectiveness of targeted prevention programs for key populations at risk HIV: Relevant Dublin indicators Hepatitis: Dublin indicators 2013 National 2020 National data, ECDC (Dublin Declaration indicators) Relevant studies EG Role: Contribution (Indirect) National authorities Cross-sectorial Vulnerable groups Health equity Innovative approaches
(migrants, MSM, CSW, HIV+, PWID, youth, prisoners) Access to prevention programs Notification rates for hepatitis B & C STI: Condom use Notification rates for STIs TB: TB incidence TB cases among foreign-born statistics for 2013 As above As above ECDC (reported incidence data) GOs and NGOs 3.2. Contribution to: Increased coverage and availability of testing and other integrated services for key populations at risk (migrants, MSM, CSW, HIV+, PWID, youth etc.) within ND Area HIV: Relevant Dublin indicators Hepatitis B&C STI amount of testing activities TB: testing percentage 2020 As above ECDC National data Relevant studies EG Role: Contribution (Indirect) National authorities GOs and NGOs Cross-sectorial Vulnerable groups Health equity Innovative approaches friendly
of HIV among TB patients 3.3. Contribution to capacity building: Improved awareness among key populations at risk and other relevant key stakeholders, about the effectiveness and importance of testing, prevention and treatment of HIV, TB and other related infections HIV: Relevant Dublin indicators Hepatitis: STI: TB: Availability of national and training programmes to prevent HIV, TB & AIs No of MDR TB cases 2020 ECDC National data Relevant studies National data EG Role: Indirect and direct National authorities GOs and NGOs Cross-sectorial Vulnerable groups Health equity Innovative approaches 4. Policy advice documents for partner countries are developed, disseminated and followed up No of relevant documents produced Countries and partners which integrate produced recommendations into policies 2020 EG Role: direct National authorities Cross-sectorial Vulnerable groups Health equity Innovative approaches Health in all policies III. Planned Activities for 2015-2017 1. Background
training activities organized by: eusafe.org, EUMS, ENETOSH, ENWHP, NIVA, IALI 6. Information dissemination through existing information systems NDPHS Database Baltic Sea Network on Occupational Health/Safety () Barents Newsletter on OH&S other newsletters publications other media No of information exchange mechanisms Visitors of websites Number of articles Each member country EG OSH FIOH FIOH All cross-cutting objectives III. Planned Activities for 2015-2017 RealOcc Accidents 1. Background us
5. Better noncommunicable disease outcomes: challenges and opportunities for health systems at the national level 6. Healthy lifestyles and healthy workplaces – a workplace health promotion project II.A Expected results No. Expected result Indicator Baseline Timing (deadline) Data source Responsible (organization(s), EGs etc) objectives 1. NCD (& ASA/PHS/OSH) Annual NCD thematic report for NDPHS geographical area published and disseminated Annual NCD thematic report for 9 partner countries published by every upcoming PAC (4th quarter each calendar year and disseminated thereafter NCD thematic report prepared by NCD-EG for PAC-8 (November 2012) 1st Thematic report by end of 2015 2nd Thematic report by end of 2017 WHO-EURO statistical data base; National statistical authorities; National health authorities. NCD-EG links with: ASA-EG PHS-EG OSH-EG reflects to all: cross-sectorial action; inclusion of vulnerable groups; health equity & social cohesion; innovative approaches & tech.; HiAP
2. NCD (& HAAI/ PHS/OSH) Tri-annual (PYLL) analysis for NDPHS geographical area by using all 12 categories of preventable premature (<70yrs) mortality data First (consisting of 2013 mortality data) published and disseminated Second (consisting of 2015 mortality data) published and disseminated Latest available OECD (years/100.000) EST:5558 FIN: 3395 GER: 3070 NOR: 2760 POL: 5171 RUS: 11544 SWE: 2487 VTU: missing LVA: missing by the end of 2016 OECD; WHO-EURO statistical data base; National statistical authorities; National health authorities. NCD-EG links with: PHS-EG OSH-EG HAAI-EG (also with HIV/AIDS EG, because both HIV and TB are preventable and/or curable diseases, which will also register Assistance needed from CSR national representatives when discussing and finding right partner(s) in national public health institutes and statistical bureaus. gender related health equity will be reflected, as PYLL-values are calculated separately for men and women Through alcohol related and HIV/AIDS and Tuberculosis related PYLL losses the situation of vulnerable groups can be highlighted. Whole concept of is an innovative concept in NDPHS area and will strengthen HiAP No. Expected result Indicator Baseline Timing (deadline) Data source Responsible (organization(s), EGs etc.) objectives 3. NCD (&/PHS/OSH) Better implementation of HiAP at local level for more effective prevention of NCDs (project activity) PYLL values of participating localities (cities or regions) (minimum 3) Latest national PYLL values of participating countries (minimum 3 countries) Latest local PYLL values of participating sites (minimum 3 Depends on successful identification of project funding. Funding for a 2-3 year long project is aimed for. Hence deadline end of 2017 Project reporting Local project implemented PYLL- values at each locality measured Project implementing consortium is formed at the time when suitable funding channel is identified NCD EG would act in a facilitating and coordinating role as has happened successfully in the St. Petersburg “Healthier People project which acts as a reflects to all: cross-sectorial action; inclusion of vulnerable groups; health equity & social cohesion; innovative approaches & tech.; HiAP PYLL- indicator lost
7. NCD (and other interested EGs as feasible) Better awareness of public health consequences of free trade agreements (FTAs) presently under negotiation in our respective countries Number of country reports on FTA impact on national health policies . Final report assessing impact of FTAs in NDPHS area and recommendations of action and follow-up needed Country reports on FTAs impact on national health policies form the initial baseline. . 2015 Country report 2016 Final assessment report National and international FTA information Ministries of Foreign Affairs Public Services International Research Unit (PSIRU/London) Canadian Centre for Policy Alternatives (CCPA National and international NGO-networks and action groups mobilized around FTAs NCD EG and to be established TASK FORCE on Free Trade Agreements from Public Health Perspective NDPHS national ministries of health and other national health policy formulating bodies ‘ representatives. WHO-EURO ILO EU reflects to : cross-sectorial action; inclusion of vulnerable groups; health equity & social cohesion; innovative approaches & tech.; HiAP ADDITIONAL INDICATOR TABLE re. NCDs II.B Expected long-term target indicators as defined by all WHO-EURO Member States (including all our 9 NDPHS partnership countries). These NCD indicators need to be kept in mind and appropriately reflected - as feasible -, when evaluating the outcomes of NDPHS’ NCD-related actions. No. Expected result 2025 Indicator
interventions and services WHO NCD action plan in the national policy documents # of countries having translated into a national policy target the global recommendation of at least 10% reduction in the harmful use of alcohol by 2025 Conference report WHO Partner organisations ASA EG and other actors of the NDPHS 2. Improved exchange of effective approaches and interventions for preventing and reducing the harmful use of alcohol, tobacco and drugs on the local level # of countries having made available national guidelines for implementing effective community based interventions to reduce the 0 2020 (Continuous) National policy documents Project reports National surveys Each Partner Country Partner organisations ASA EG and other actors of the NDPHS All cross-cutting objectives
public health policies on alcohol and drugs infections diseases – percentage of IDUs who are HIV infected / new HIV infections prevented among people who use drugs Availability of comparable data across partnership countries on drinking habits and alcohol related harm. Availability of comparative information across partnership countries on responses to current EE FI LT LV NO PL RF SE Projects reports National surveys WHO EMCDDA Partner organisations ASA EG and other actors of the NDPHS
challenges in the drugs field 5. Better policy responses in the field of alcohol affordability and trade, to reduce harm from alcohol Total yearly per capita (15 years+) consumption of pure alcohol Inventory of affordability changes over time in the NDPHS countries, as recommended by WHO. GE EE FI LT LV NO PL RF SE 2020 National statistics National surveys WHO Each Partner Country Partner organisations ASA EG All cross-cutting objectives III. Planned Activities for 2015-2017 1. Background border
Activities: The project will consist of in-depth epidemiological analyses analyses of treatment and early intervention offers sharing the experiences looking for best practices analyses of drug policy context formulation of policy recommendations for improving cannabis policy including treatment and early intervention offers The summery of the report will be translated into national languages and broadly disseminated in all NDPHS countries. The feedback from national experts, professionals and activists will be collected, summarised and then discussed within the ASA EG. 3. Target group(s) General population Adolescent population Policy makers Public health specialists 4. Resources No resources available at this moment. It is foreseen that project proposals will be developed and the NDPHS partner countries will assist in finding necessary resources for the implementation of the planned activities
Network of laboratories. 1.3 Comparable prevalence data of ESBL carriage in the general public. 1.4 Comparable data of resistance levels in infections not normally cultivated and AST-tested. Completed comparison of resistance levels in uncomplicated UTIs. nominator is therefore not always comparable. Lack of data comparable between countries on the frequency of carriage. Lack of resistance data in infections not normally cultivated. 2. AB-use: Establish appropriate key indicators for antibiotic use in member states. Number of NDPHS member countries that use these indicators in their national surveillance. A few countries have key indicators and some are in the process of developing and validating. 1 January 2018 AMR-TG Promote the inclusion of vulnerable groups. 3. Promote Rational use: A compilation of appropriate guidelines relevant to the region in general, but where regional and national variations A publication of the compiled guidelines. Knowledge dissemination, through information campaigns towards target groups (III.3.). Possible revision of national guidelines. There is no overarching view of the guidelines in the NDPHS area. There is also little information on the knowledge base in the NDPHS area. 1 January 2018 AMR-TG Promote a Health in All Policies approach. Promote health equity and social cohesion in all actions. Promote the
related to increasing prevalence of multimorbidity in the elderly population and of the ways on how health systems respond to it. The TT Media presentations PAC side event Number of national policy documents approved by national authorities documents concerning needs for the growing number of elderly patients with during the inception phase of the flagship project Policy paper on integrated care, Newsletter, PAC side event including preparation of statement 1.2 The Care processes/pathways of multimorbid patients are investigated; problem areas and opportunities for improvement are better known Number of countries where investigated for the target group are identified 2017 National data selected during the inception phase of the flagship project IntegBalt project partners (in case of successful application) 1.3. Dissemination of the experiences and solutions on how to improve the care for the target group Deliverables: International workshop with aim to share experiences Synthesis report on experiences and solutions on how to improve care
1.4 Enhanced capacities of professionals (from core PHC and extended PHC team) Same (not to delete Number of professionals who enhanced their competences in regard of the integrated care (persons trained, number of training days) Number of newly introduced staff members 2018 IntegBalt project partners (in case of successful application) 1.5. A legal and regulatory framework is adapted/revised to address the needs of integrated and coordinated care for patients with multimorbidity Number of revised/newly introduced legal documents Number of countries with existing legal framework 2020 IntegBalt project partners (in case of successful application) 1.6. A better integration and coordination of care of patients with comorbidity through Introduction of care plans for the care of patients with multimorbidity Raise in number of countries where care plans are used for multimorbid patients Number of countries with existing care plans for the target group 2020 2. Patients and their families are more empowered to take active part in the care of their Raise in number of countries where in care Number of countries where in 2018 IntegBalt project partners (in case of successful All crosscutting objectives particularly:
own health, including plans is clearly stated the role of patients and their families as active participants in the care Estimated proportion of care plans where the patients and their families have taken an active part. care plans is stated the role of patients and their families as active participants application) Promote innovative approaches and technologies, such as eHealth Promote cross-sectorial action 2.1. Expanded use of peer groups for different groups of patients aimed to learn and to change experiences in coping with diseases Raise in number of groups of patients identified in countries Number of countries… 2018 IntegBalt project partners (in case of successful application) 2.2 Defined role of patients and families in management of chronic illness in the care plan Raise in number of countries where plans with an identified role of patients and families are introduced Number of countries…. 2018 IntegBalt project partners (in case of successful application) 2.3. Introduced measures, including IT tools which facilitates Raise in the number of Number of countries… 2018 IntegBalt project partners (in case
and patient education countries were evidence based measures are introduced. of successful application) 3 Resource allocation and incentives to health and social care providers support integrated and better coordinated care Raise in number of countries where payment to providers have been revised to support integrated care Number of countries…. 2018 IntegBalt project partners (in case of successful application) All cross cutting objectives, particularly: Promote cross-sectorial action; Promote the inclusion of vulnerable groups; Promote health equity and social cohesion in all actions 3.1. Developed methodologies for more costeffective resource allocation towards needs of particular population Degree of the use of recommended priority setting 2018 IntegBalt project partners (in case of successful application) 3.2 Introduction of methodologies for more costeffective resource allocation 2020 Integbalt project partners. All ND countries active in the partnership 3.3 Developed and tested models of payments aimed to provide more appropriate and costeffective services for patients with multimorbidity Raise in developed and tested models in ND countries Number of countries with existing models 2020 Integbalt project partners. All ND countries active in the partnership 4. The Psychosocial causes of NCD risk factors are better identified and addressed for of new methodologies Number of countries with existing 2020 All ND countries active in the partnership Promote cross-sectorial action; Promote the inclusion of
Date submitted: Oct 10th, 2014 I. Objective(s): Implement adequate health protection in prisons correctional facilities (additional objective proposedby prison health experts of the PPHS EG) II. Expected results No. Expected result Indicator Timing (deadline) Data source Responsible (organization(s), EGs etc) Cross-cutting objectives 1. Improved infections disease control, esp. regarding HIV, TB and HIV-TB. Implementation of particular instruments / model solutions for tb control adjusted to specific local conditions. Special focus on MDR and XDR TB and prevention and detection of resistance Incidence of HIV, TB and HIV+TB in Prisons and correctional facilities in accordance to rate of testing of HIV/TB Expected: After increased testing period increased incidence, then continuous decrease till the end of strategy. Rate of patients To be added 2020 National data Relevant National authorities 1,2,3,5,
WHO/HIPP standards are achieved Expected qualitative Indicator 2.1 Reduce imprisonment “ 2.1.1. Use alternative forms of punishment Collect and distribute information about good practice using alternative forms of punishment “ To be added 2020 National data EG, national bodies 1,2,3,4,5 2.1.2 Revise terms of imprisonment Collect and distribute scientific information on social economic factors regarding harmful effects from imprisonment Evaluate and balance punitive level for drug addiction relative to prevention, treatment and rehabilitation “ To be added 2020 National data National Government EG PPHS and HIV 1,2,5 2.1.3 Early intervention to prevent criminal “ “ 2020 National Data Relevant nationals 1,2,4,5
behaviour, drug addiction, antisosial behaviour, prevent discrimination, social exclusion, mobbing, good education, low socio- economic differences, Activities: Make politicians and poicy makers avere of harm from imprisonment, economic cost of imprisonment compared with alternatives, Calculate/estimate costs for imprisonment –policy papers Describe harm from imprisonment Introduce principle of normalisation – prevent institunonalisation Arranging seminars throughout the ND area for decision makers Increase political awareness for the authorizes, NDPHS bodies, EG PPHS, ASA,
harm from imprisonment as a public health challenge 2.2 Building more healthy conditions in prisons Reduce overcrowding Introduce the principle of normalization Implement minimum standards COE/CPT Healthy prison – following WHO recommendations for prison health “ “ “ “ Relevant nationals authorizes 1,2,3,5 3. Improved „throughcare“, (throughcare in this context is optimized medical care process from inside to outside an vice verse). Improved collaboration between the prison health system and the health care in the community 1. Rate of fulfilled for TB cases at release Expected: increase 2. Established and followed routine of Through-care Expected: qualitative Indicator “ “ “ Relevant nationals authorizes EG PPHS 1,2,3,4,5
agendas of regional events) Indicator target value: At least one event each year. 2. Strengthened support from and involvement of external stakeholders in the NDPHS-facilitated activities Indicator name: Number of new external organizations and/or authorities involved in activities, representing at least three actors per each of the following sectors: international or regional; national; sub-national and local; NGOs/civil society representatives Indicator target value: At least twenty Status as of the end of 2013 (the names of the external stakeholders already cooperating with/ involved in the NDPHS can be found in the Report on the implementation of the NDPHS Strategy in 2010-2013) 2020 NDPHS Annual Progress Reports All NDPHS actors Promote action 3. Increased and strengthened cycle approach in the regional cooperation in the area of health and social well-being (the NDPHS is to help convey relevant results and Indicator 3.1 name: Number of NDPHS events per year used by the CSR/PAC and the NDPHS Expert Groups to help convey the results of or projects to the policy level. Status as of the end of 2014. 2020 NDPHS Annual Progress Reports, NDPHS meeting minutes All NDPHS actors Promote action; Promote a Health in All Policies approach
recommendations of ongoing and completed projects to the policy level, however, this element has not been explored by the NDPHS to the fullest). Indicator 3.2 name: Number of non-NDPHS events per year used by the CSR/PAC and the NDPHS Expert Groups to help convey the results of or projects to the policy level. Indicator 3.1 and 3.2 target values: At least one event each year (per each indicator). 4. Increased visibility of the NDPHS in the Partner Countries Indicator 4.1 name: Number of dedicated meetings and consultations held by each NDPHS Chairmanship [(supported by the NDPHS Secretariat, if necessary)] held with all NDPHS Partner Countries to help improve the visibility of the Partnership in the capitals of the Partner Countries. Baseline 4.1: Status as of the end of 2013 Baseline 4.2: Status as of October 2014: (i) Partners who provide a link to the NDPHS on their homepages: Finland, Germany, Latvia, Norway, BEAC, BSSSC, CBSS, WHO Deadline 4.1: 2020 Deadline 4.2: 2015 NDPHS Annual Progress Reports NDPHS Partner Countries Promote action; Promote a Health in All Policies approach